Logo image of ALAFY.PA

AFYREN SAS (ALAFY.PA) Stock Fundamental Analysis

EPA:ALAFY - Euronext Paris - Matif - FR0014005AC9 - Common Stock - Currency: EUR

2.7  +0.02 (+0.75%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to ALAFY. ALAFY was compared to 67 industry peers in the Chemicals industry. ALAFY scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ALAFY is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ALAFY had negative earnings in the past year.
In the past year ALAFY has reported a negative cash flow from operations.
ALAFY had negative earnings in each of the past 5 years.
In the past 5 years ALAFY always reported negative operating cash flow.
ALAFY.PA Yearly Net Income VS EBIT VS OCF VS FCFALAFY.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -2M -4M -6M -8M

1.2 Ratios

ALAFY has a worse Return On Assets (-16.66%) than 83.58% of its industry peers.
The Return On Equity of ALAFY (-18.51%) is worse than 74.63% of its industry peers.
Industry RankSector Rank
ROA -16.66%
ROE -18.51%
ROIC N/A
ROA(3y)-13.7%
ROA(5y)-10.19%
ROE(3y)-15.66%
ROE(5y)-12.5%
ROIC(3y)N/A
ROIC(5y)N/A
ALAFY.PA Yearly ROA, ROE, ROICALAFY.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -10 -20 -30

1.3 Margins

The Gross Margin of ALAFY (88.40%) is better than 100.00% of its industry peers.
In the last couple of years the Gross Margin of ALAFY has declined.
ALAFY does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 88.4%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.47%
GM growth 5Y-1.95%
ALAFY.PA Yearly Profit, Operating, Gross MarginsALAFY.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

More info and screens

6

2. Health

2.1 Basic Checks

ALAFY does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ALAFY has been increased compared to 1 year ago.
ALAFY has more shares outstanding than it did 5 years ago.
ALAFY has a better debt/assets ratio than last year.
ALAFY.PA Yearly Shares OutstandingALAFY.PA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
ALAFY.PA Yearly Total Debt VS Total AssetsALAFY.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

ALAFY has an Altman-Z score of 6.99. This indicates that ALAFY is financially healthy and has little risk of bankruptcy at the moment.
ALAFY has a better Altman-Z score (6.99) than 97.01% of its industry peers.
A Debt/Equity ratio of 0.04 indicates that ALAFY is not too dependend on debt financing.
ALAFY's Debt to Equity ratio of 0.04 is amongst the best of the industry. ALAFY outperforms 94.03% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Altman-Z 6.99
ROIC/WACCN/A
WACC7.58%
ALAFY.PA Yearly LT Debt VS Equity VS FCFALAFY.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

ALAFY has a Current Ratio of 15.87. This indicates that ALAFY is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of ALAFY (15.87) is better than 100.00% of its industry peers.
ALAFY has a Quick Ratio of 15.87. This indicates that ALAFY is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 15.87, ALAFY belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 15.87
Quick Ratio 15.87
ALAFY.PA Yearly Current Assets VS Current LiabilitesALAFY.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for ALAFY have decreased by -1.24% in the last year.
The Revenue for ALAFY has decreased by -15.30% in the past year. This is quite bad
Measured over the past years, ALAFY shows a small growth in Revenue. The Revenue has been growing by 4.31% on average per year.
EPS 1Y (TTM)-1.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1.05%
Revenue 1Y (TTM)-15.3%
Revenue growth 3Y-1.95%
Revenue growth 5Y4.31%
Sales Q2Q%5.27%

3.2 Future

The Earnings Per Share is expected to grow by 13.62% on average over the next years. This is quite good.
Based on estimates for the next years, ALAFY will show a very strong growth in Revenue. The Revenue will grow by 70.16% on average per year.
EPS Next Y20%
EPS Next 2Y2.2%
EPS Next 3Y13.62%
EPS Next 5YN/A
Revenue Next Year27.52%
Revenue Next 2Y22.76%
Revenue Next 3Y70.16%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALAFY.PA Yearly Revenue VS EstimatesALAFY.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 5M 10M 15M
ALAFY.PA Yearly EPS VS EstimatesALAFY.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 -0.1 -0.2 -0.3 -0.4

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ALAFY reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALAFY. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALAFY.PA Price Earnings VS Forward Price EarningsALAFY.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALAFY.PA Per share dataALAFY.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

A more expensive valuation may be justified as ALAFY's earnings are expected to grow with 13.62% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y2.2%
EPS Next 3Y13.62%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALAFY!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AFYREN SAS

EPA:ALAFY (6/30/2025, 7:00:00 PM)

2.7

+0.02 (+0.75%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners12.35%
Inst Owner ChangeN/A
Ins Owners10.68%
Ins Owner ChangeN/A
Market Cap70.50M
Analysts86
Price Target5.1 (88.89%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)17.65%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)14.96%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)9.1%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 24.63
P/FCF N/A
P/OCF N/A
P/B 1.34
P/tB 1.42
EV/EBITDA N/A
EPS(TTM)-0.37
EYN/A
EPS(NY)-0.37
Fwd EYN/A
FCF(TTM)-0.22
FCFYN/A
OCF(TTM)-0.22
OCFYN/A
SpS0.11
BVpS2.02
TBVpS1.91
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -16.66%
ROE -18.51%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 88.4%
FCFM N/A
ROA(3y)-13.7%
ROA(5y)-10.19%
ROE(3y)-15.66%
ROE(5y)-12.5%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.47%
GM growth 5Y-1.95%
F-Score4
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 25.97%
Cap/Sales 7.72%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 15.87
Quick Ratio 15.87
Altman-Z 6.99
F-Score4
WACC7.58%
ROIC/WACCN/A
Cap/Depr(3y)59.69%
Cap/Depr(5y)64.66%
Cap/Sales(3y)13.21%
Cap/Sales(5y)12.63%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1.05%
EPS Next Y20%
EPS Next 2Y2.2%
EPS Next 3Y13.62%
EPS Next 5YN/A
Revenue 1Y (TTM)-15.3%
Revenue growth 3Y-1.95%
Revenue growth 5Y4.31%
Sales Q2Q%5.27%
Revenue Next Year27.52%
Revenue Next 2Y22.76%
Revenue Next 3Y70.16%
Revenue Next 5YN/A
EBIT growth 1Y-2.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year45.95%
EBIT Next 3Y22.09%
EBIT Next 5YN/A
FCF growth 1Y-4.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-11.55%
OCF growth 3YN/A
OCF growth 5YN/A